S&P 5007,713▲ 0.28%Nasdaq26,425▼ 0.02%Dow Jones52,496▲ 1.02%Nasdaq 10029,490▼ 0.13%VIX17.31▼ 6.13%US Dollar101.73▼ 0.25%Gold spot4,145▲ 0.30%WTI spot101.91▲ 1.04%
Home › S1NP34 › Research report
← S1NP34 page
XStocksXray
Market X-Ray report · 20 October 2026

Synopsys, Inc. (S1NP34)

Sao Paulo Exchange · Brazil · prices in BRL · close of 20 Oct 2026

Key indicators

Last closeBRL 56.34
52-week range46.90 – 71.40
Return, 1 month / 3 months+11.6% / +14.4%
Return, 1 year / 3 years−6.4% / −7.9%
TrendBelow its 200-day average
RSI (14)47
Volatility (1 year)45.7%
Worst drawdown (1 year)-34.3%
Average daily value traded1.07M BRL
Dividend yield–

Market X-Ray price-based

49/ 100 · High confidence · ahead of 46% of stocks on this exchange
Trend40
Momentum48
Stability (higher is calmer)41
Liquidity81
Income–

Five-year price chart navy: price · brown: 200-day average

30.7846.2061.6277.0492.462021-102023-012024-042025-072026-10

About the company

Synopsys, Inc. supplies software and intellectual property that engineers use to design and verify integrated circuits and electronic systems. Its tools help chip designers and electronics manufacturers develop semiconductors and the software that runs on them. The company also offers verification platforms and design services. Synopsys is based in the United States and serves technology and semiconductor customers around the world.

Synopsys, Inc. is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code S1NP34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Synopsys, Inc. (S1NP34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 56.34 on 20 October 2026.

Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 788 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 6.4% and over the last three months it rose 14.4%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Synopsys, Inc. (S1NP34)

The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange

Lens and metricValueScoreReading
Trend40 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-1.7%
From 52-week high-21.1%
Momentum48 · WeakLagging most stocks on this exchange.
3-month return14.4%
6-month return-1.9%
12-month return, skipping the last month-16.1%
Stability (higher is calmer)41 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)45.7%
Worst drawdown, 1 year (smaller is calmer)-34.3%
Liquidity81 · StrongTrades actively.
Average daily value traded1.07M BRL
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−9.6%
1 month+11.6%
3 months+14.4%
6 months−1.9%
1 year−6.4%
3 years−7.9%
5 years–

Signals

50-day / 200-day average54.83 / 57.33
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.72

Technical summary

DailyNeutral7 bullish · 2 neutral · 7 bearish
WeeklyBearish4 bullish · 1 neutral · 7 bearish
MonthlyStrongly bearish1 bullish · 1 neutral · 6 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 21 Oct 2026